U. Gudat

528 total citations
12 papers, 304 citations indexed

About

U. Gudat is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pharmacology. According to data from OpenAlex, U. Gudat has authored 12 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Surgery and 3 papers in Pharmacology. Recurrent topics in U. Gudat's work include Diabetes Management and Research (8 papers), Diabetes Treatment and Management (6 papers) and Pharmacology and Obesity Treatment (3 papers). U. Gudat is often cited by papers focused on Diabetes Management and Research (8 papers), Diabetes Treatment and Management (6 papers) and Pharmacology and Obesity Treatment (3 papers). U. Gudat collaborates with scholars based in Germany, United States and Australia. U. Gudat's co-authors include Anselm K. Gitt, Helmut O. Steinberg, Elizabeth Barrett‐Connor, Elsa‐Grace V. Giardina, Diethelm Tschoepe, Lutz Heinemann, Paris Roach, Tim Heise, Christian Weyer and F. W. Kemmer and has published in prestigious journals such as Diabetes Care, Diabetic Medicine and Diabetes Research and Clinical Practice.

In The Last Decade

U. Gudat

12 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. Gudat Germany 7 190 86 74 59 46 12 304
V A Koivisto Finland 5 239 1.3× 67 0.8× 75 1.0× 54 0.9× 89 1.9× 7 362
Xiaojun Luan China 8 204 1.1× 86 1.0× 79 1.1× 36 0.6× 74 1.6× 11 343
Wolfgang Hecker Germany 8 231 1.2× 95 1.1× 83 1.1× 32 0.5× 138 3.0× 17 412
Bethany Warren United States 7 369 1.9× 67 0.8× 66 0.9× 44 0.7× 62 1.3× 13 465
Mario Molina-Ayala Mexico 9 105 0.6× 128 1.5× 43 0.6× 94 1.6× 34 0.7× 28 327
Nobuichi Kuribayashi Japan 12 286 1.5× 92 1.1× 104 1.4× 56 0.9× 18 0.4× 26 431
Juana A. Flores-Le-Roux Spain 8 233 1.2× 167 1.9× 54 0.7× 90 1.5× 113 2.5× 12 402
Marta Bueno Spain 11 84 0.4× 110 1.3× 48 0.6× 85 1.4× 73 1.6× 33 298
Arlette Soros United States 8 218 1.1× 47 0.5× 78 1.1× 68 1.2× 50 1.1× 14 333
S. Gudbjornsdottir Sweden 6 268 1.4× 126 1.5× 48 0.6× 37 0.6× 118 2.6× 13 339

Countries citing papers authored by U. Gudat

Since Specialization
Citations

This map shows the geographic impact of U. Gudat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Gudat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Gudat more than expected).

Fields of papers citing papers by U. Gudat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Gudat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Gudat. The network helps show where U. Gudat may publish in the future.

Co-authorship network of co-authors of U. Gudat

This figure shows the co-authorship network connecting the top 25 collaborators of U. Gudat. A scholar is included among the top collaborators of U. Gudat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Gudat. U. Gudat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Reichel, Andreas, Hannes Rietzsch, H. Köhler, et al.. (2009). Cessation of insulin infusion at night-time during CSII-therapy: Comparison of regular human insulin and insulin lispro. Experimental and Clinical Endocrinology & Diabetes. 106(3). 168–172. 11 indexed citations
3.
Barrett‐Connor, Elizabeth, Elsa‐Grace V. Giardina, Anselm K. Gitt, et al.. (2004). Women and Heart Disease. Archives of Internal Medicine. 164(9). 934–934. 143 indexed citations
4.
Först, Thomas, J Eriksson, Shi Bai, et al.. (2003). Metabolic Effects of Mealtime Insulin Lispro in Comparison to Glibenclamide in Early Type 2 Diabetes. Experimental and Clinical Endocrinology & Diabetes. 111(2). 97–103. 11 indexed citations
5.
6.
Roach, Paris, et al.. (2000). Improved glucose control following administration of a 75% insulin lispro/25% NPL mixture in patients with type 1 diabetes. Diabetes Research and Clinical Practice. 50. 220–221. 1 indexed citations
7.
Gudat, U., et al.. (2000). Intravenous administration of insulin lispro versus regular human insulin in patients with type 1 diabetes. Diabetes Research and Clinical Practice. 50. 77–77. 1 indexed citations
8.
Gudat, U., et al.. (1998). The blood glucose lowering effects of exercise and glibenclamide in patients with Type 2 diabetes mellitus. Diabetic Medicine. 15(3). 194–198. 22 indexed citations
9.
Heise, Tim, et al.. (1998). Time-Action Profiles of Novel Premixed Preparations of Insulin Lispro and NPL Insulin. Diabetes Care. 21(5). 800–803. 77 indexed citations
10.
Gudat, U., et al.. (1997). Metformin and Exercise: no Additive Effect on Blood Lactate Levels in Healthy Volunteers. Diabetic Medicine. 14(2). 138–142. 10 indexed citations
11.
Gudat, U. & L Heinemann. (1996). Ø[The effect of physical exercise on glycemia on healthy subjects following administration of glimepiride].. PubMed. 46(6). 606–9. 1 indexed citations
12.
Gudat, U., et al.. (1994). Physical activity, fitness, and non-insulin-dependent (type II) diabetes mellitus.. 669–683. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V A Koivisto Breakdown of academic impact, for papers by Xiaojun Luan Breakdown of academic impact, for papers by Wolfgang Hecker Breakdown of academic impact, for papers by Bethany Warren Breakdown of academic impact, for papers by Mario Molina-Ayala Breakdown of academic impact, for papers by Nobuichi Kuribayashi Breakdown of academic impact, for papers by Juana A. Flores-Le-Roux Breakdown of academic impact, for papers by Marta Bueno Breakdown of academic impact, for papers by Arlette Soros Breakdown of academic impact, for papers by S. Gudbjornsdottir
Rankless by CCL
2026